Preferred Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
Preferred Pharmaceuticals is recalling 480 bottles of Artificial Tears (Glycerin) eye drops due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II due to a lack of assurance of sterility in ophthalmic products, which poses a risk of serious adverse health consequences. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling 480 bottles of Artificial Tears (Glycerin) Lubricant Eye Drops. The recall was initiated because of a lack of assurance of sterility in the product.
The affected product is sold under the brand name Artificial Tears and is manufactured by Geri-Care in Brooklyn, NY. The recall covers specific lots with expiration dates ranging from February 2027 to November 2027. The product was distributed nationwide in the United States.
Consumers who have purchased these specific lots should stop using the product and contact their healthcare provider or the manufacturer for further instructions.
The recalled product
- Product
- ARTIFICIAL TEARS (GLYCERIN)
- Brand
- ARTIFICIAL TEARS
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 480
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot C2825L
- Exp 2/28/2027 Lot G1825U
- Exp 11/30/2027 Lot D1326B
- Exp 11/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ARTIFICIAL TEARS
- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighArtificial tears glycerin drops recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-08
- SevereArtificial Tears Eye Drops Recalled for Manufacturing and Sterility Issues
FDA (Drugs) · 2025-05-14
Same manufacturer · Preferred Pharmaceuticals, Inc.
See all →- ModeratePreferred Pharmaceuticals Recalls Lidocaine Ointment Due to Content Uniformity Failures
FDA (Drugs) · 2026-10-14
- ModerateOndansetron blister packs recalled because tablets are falling out
FDA (Drugs) · 2025-12-24
- ModerateClindamycin Hydrochloride Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-07
- HighIbuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-09-04
- HighDuloxetine Delayed-Release Capsules Recalled for Nitrosamine Impurity
FDA (Drugs) · 2024-05-29
Same hazard · sterility
See all →- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereEagle Pharma Recalls Phenylephrine Infusion Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- SevereEagle Pharma Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- SevereFDA Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-28
- SevereHeparin Sodium Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-28
Similar recalls
- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighArtificial tears glycerin drops recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-08
- SevereArtificial Tears Eye Drops Recalled for Manufacturing and Sterility Issues
FDA (Drugs) · 2025-05-14
- SevereK.C. Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereOasis Tears PF Lubricant Eye Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-20
- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14